CONMED CORPORATION Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax
CONMED CORPORATION (CNMD) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax of -$3.03 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax · last filed 2020-10-29
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2020-09-30 was -$3.03M, a 258.02% decline year-over-year.
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2020-06-30 was -$2.43M.
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2020-03-31 was $2.40M, a 2168.87% increase year-over-year.
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2019-09-30 was $1.92M, a 61.60% increase year-over-year.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 9 month |
|---|---|---|---|
| 2020-09-30 | -$3.03M 10-Q · filed 2020-10-29 | -$5.46M derived: sum of 2 quarters · filed 2020-10-29 | -$3.05M 10-Q · filed 2020-10-29 |
| 2020-06-30 | -$2.43M 10-Q · filed 2020-07-30 | -$24.00K 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $2.40M 10-Q · filed 2020-04-30 | ||
| 2019-09-30 | $1.92M 10-Q · filed 2020-10-29 | $317.00K derived: sum of 2 quarters · filed 2020-10-29 | $423.00K 10-Q · filed 2020-10-29 |
| 2019-06-30 | -$1.60M 10-Q · filed 2020-07-30 | -$1.49M 10-Q · filed 2020-07-30 | |
| 2019-03-31 | $106.00K 10-Q · filed 2020-04-30 | ||
| 2018-09-30 | $1.19M 10-Q · filed 2019-10-31 | $5.01M derived: sum of 2 quarters · filed 2019-10-31 | $6.60M 10-Q · filed 2019-10-31 |
| 2018-06-30 | $3.83M 10-Q · filed 2019-08-01 | $5.41M 10-Q · filed 2019-08-01 | |
| 2018-03-31 | $1.59M 10-Q · filed 2019-04-26 | ||
| 2017-09-30 | -$1.35M 10-Q · filed 2018-11-02 | -$3.10M derived: sum of 2 quarters · filed 2018-11-02 | -$3.95M 10-Q · filed 2018-11-02 |
| 2017-06-30 | -$1.75M 10-Q · filed 2018-08-02 | -$2.60M 10-Q · filed 2018-08-02 | |
| 2017-03-31 | -$847.00K 10-Q · filed 2018-04-26 | ||
| 2016-09-30 | -$824.00K 10-Q · filed 2017-11-02 | $313.00K derived: sum of 2 quarters · filed 2017-11-02 | -$1.90M 10-Q · filed 2017-11-02 |
| 2016-06-30 | $1.14M 10-Q · filed 2017-07-27 | -$1.08M 10-Q · filed 2017-07-27 | |
| 2016-03-31 | -$2.22M 10-Q · filed 2017-04-27 | ||
| 2015-09-30 | -$361.00K 10-Q · filed 2016-10-28 | -$2.92M derived: sum of 2 quarters · filed 2016-10-28 | -$956.00K 10-Q · filed 2016-10-28 |
| 2015-06-30 | -$2.56M 10-Q · filed 2016-07-28 | -$595.00K 10-Q · filed 2016-07-28 | |
| 2015-03-31 | $1.96M 10-Q · filed 2016-05-02 | ||
| 2014-09-30 | $3.57M 10-Q · filed 2015-10-23 | $3.04M derived: sum of 2 quarters · filed 2015-10-23 | $3.76M 10-Q · filed 2015-10-23 |
| 2014-06-30 | -$528.00K 10-Q · filed 2015-07-27 | $197.00K 10-Q · filed 2015-07-27 | |
| 2014-03-31 | $725.00K 10-Q · filed 2015-04-24 | ||
| 2013-09-30 | -$2.41M 10-Q · filed 2014-10-24 | -$2.03M derived: sum of 2 quarters · filed 2014-10-24 | $96.00K 10-Q · filed 2014-10-24 |
| 2013-06-30 | $379.00K 10-Q · filed 2014-07-25 | $2.51M 10-Q · filed 2014-07-25 | |
| 2013-03-31 | $2.13M 10-Q · filed 2014-04-25 | ||
| 2012-09-30 | -$1.61M 10-Q · filed 2013-10-28 | -$1.31M derived: sum of 2 quarters · filed 2013-10-28 | -$2.88M 10-Q · filed 2013-10-28 |
| 2012-06-30 | $292.00K 10-Q · filed 2013-07-29 | -$1.27M 10-Q · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |